STEPHEN THOMAS: Open Payments
NPI 1841769700 · CATLETTSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 24 payments from 7 companies in 2025. Trend: 2023 $120 · 2024 $377 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $108 |
| Novo Nordisk Inc | 5 | $99 |
| ABBVIE INC. | 5 | $90 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: MOUNJARO, VRAYLAR, BREZTRI, Rybelsus, Ozempic, Kerendia, JARDIANCE, REXULTI.
Industry payments across KY — which companies pay providers there.
